Emerging treatment options for the management of pemphigus vulgaris
K Kridin - Therapeutics and clinical risk management, 2018 - Taylor & Francis
Pemphigus vulgaris (PV) is a life-threatening disease belonging to the pemphigus group of
autoimmune intra-epidermal bullous diseases of the skin and mucosae. The therapeutic …
autoimmune intra-epidermal bullous diseases of the skin and mucosae. The therapeutic …
COVID vaccination in patients under treatment with rituximab: a presentation of two cases from Iran and a review of the current knowledge with a specific focus on …
SARS‐COV2 vaccines were approved without long‐term monitoring due to emergent
situations. This has raised some issues about the timing and protocol of receiving vaccines …
situations. This has raised some issues about the timing and protocol of receiving vaccines …
British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017
British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris
2017 | British Journal of Dermatology | Oxford Academic Skip to Main Content Advertisement …
2017 | British Journal of Dermatology | Oxford Academic Skip to Main Content Advertisement …
A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata
N Ghandi, R Daneshmand, P Hatami, R Abedini… - International …, 2021 - Elsevier
Background Alopecia areata (AA) is a chronic autoimmune disorder. Finding the best
treatment regimen for it remains a challenge. Currently, one of the best documented …
treatment regimen for it remains a challenge. Currently, one of the best documented …
Pemphigus vulgaris: an evidence-based treatment update
CY Zhao, DF Murrell - Drugs, 2015 - Springer
Background While a variety of intervention options have been described for pemphigus
vulgaris, the optimal treatment strategy has not been established. Objectives The objective …
vulgaris, the optimal treatment strategy has not been established. Objectives The objective …
Multiple cycles of rituximab therapy for pemphigus: a group of patients with difficult‐to‐treat disease or a consequence of late rituximab initiation?
Pemphigus is a serious autoimmune disease with few appropriate therapeutic options.
Although rituximab (RTX) has recently shown great promise in this regard, the best protocol …
Although rituximab (RTX) has recently shown great promise in this regard, the best protocol …
Influence of narrow-band ultra violet B phototherapy on homocysteine status: a prospective study of patients with different cutaneous disorders
Z Aryanian, N Shojaee, A Goodarzi… - … , and Laser Surgery, 2021 - liebertpub.com
Background: Artificial ultraviolet (UV) radiation is a mainstay in the treatment of a variety of
inflammatory skin disorders. Despite existence from a wealth of studies on the impact of …
inflammatory skin disorders. Despite existence from a wealth of studies on the impact of …
A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata
Background Alopecia areata (AA) is a chronic disorder and the best treatment regimen for it
is unknown. Currently, one of the best documented treatment modalities for AA is topical …
is unknown. Currently, one of the best documented treatment modalities for AA is topical …
Serious health threat of mucormycosis during the ongoing COVID‐19 pandemic: what dermatologists need to know in this regard
Background Recently, a surge of mucormycosis in patients affected with or recovered from
SARS‐Cov‐2 has been noted, especially in developing countries such as India, Pakistan …
SARS‐Cov‐2 has been noted, especially in developing countries such as India, Pakistan …
World Workshop on Oral Medicine VI: a systematic review of the treatment of mucocutaneous pemphigus vulgaris
R McMillan, J Taylor, M Shephard, R Ahmed… - Oral surgery, oral …, 2015 - Elsevier
Objective To determine the efficacy and safety of interventions for pemphigus vulgaris (PV).
Study Design We conducted a systematic review from 2003 to 2013 according to the …
Study Design We conducted a systematic review from 2003 to 2013 according to the …